Alexey Vanichkin

Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors

Abraham Novogrodsky, Alexey Vanichkin, Miriam Patya et al. · Science · 1994 · 337 citations

Immunology, Cell Death, Cellular Pharmacology +21

Ferrocene‐induced lymphocyte activation and antitumor activity is mediated by redox‐sensitive signaling

Riva Kovjazin, Tova Eldar, Miriam Patya et al. · The FASEB Journal · 2003 · 61 citations

Antitumor Activity, Immunotoxicology, Iron Metabolism +18

Involvement of Tumor Necrosis Factor Alpha and Interleukin-1β in Enhancement of Pentylenetetrazole-Induced Seizures Caused by <i>Shigella dysenteriae</i>

Yael Yuhas, Lester M. Shulman, Abraham Weizman et al. · Infection and Immunity · 1999 · 55 citations · Full text

Vascularization of wide pore agarose–gelatin cryogel scaffolds implanted subcutaneously in diabetic and non-diabetic mice

Konstantin Bloch, Alexey Vanichkin, Lilija G. Damshkaln et al. · Acta Biomaterialia · 2009 · 50 citations

Tissue Engineering, Regenerative Medicine, Vascular Tissue Engineering +12

Late Administration of a Lipophilic Tyrosine Kinase Inhibitor Prevents Lipopolysaccharide and Escherichia coli-Induced Lethal Toxicity

Alexey Vanichkin, Miriam Patya, Aviv Gazit et al. · The Journal of Infectious Diseases · 1996 · 43 citations

Immunology, Cell Death, Antimicrobial Chemotherapy +24